Tan Kevin 4

What Happened Kevin Tan, Chief Financial Officer and Treasurer of Solid Biosciences (SLDB), disposed of 14,783 shares on 2026-02-04. The reported weighted-average sale price was $6.44 (actual trades ranged $6.28–$6.60), for total gross proceeds of approximately $95,231. According to the filing, the sale was a sell-to-cover to satisfy tax withholding on vested restricted stock units and was made under a durable automatic sale instruction (sell-to-cover election) adopted August 15, 2024 — not a discretionary trade.

Key Details

• Transaction date: 2026-02-04; Form 4 filed: 2026-02-06 (appears timely; no late filing indicated).
• Shares sold: 14,783; reported weighted-average price: $6.44; price range: $6.28–$6.60.
• Gross proceeds: ~$95,231.
• Reason/footnote: Sale made to cover withholding taxes after RSU vesting under a sell-to-cover instruction (Footnote F1); not a discretionary sale.
• Footnote on pricing (F2): weighted-average price reported; multiple trades at different prices — issuer/SEC staff can request a per-price breakdown.
• Shares owned after transaction: not specified in the provided excerpt.

Context

• This was a tax-withholding sell-to-cover following RSU vesting, which is common and generally administrative in nature rather than a signal about the insider’s view of the company.
• Transaction code: S = Sale; Footnote indicates the sale resulted from the vesting/tax withholding process rather than an active market-timing decision.